Form D · Biotechnology

Batu Biologics, Inc.

San Diego, CA · CIK 0001612629

Offering snapshot reported May 10, 2017 · SEC filing

Reported sold: $508K
Investors reported: 9
Minimum accepted: $10K
First sale: Jan 15, 2016

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$100,000 → $508,000
Reported investors1 → 9
Minimum accepted$25,000 → $10,000

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
May 10, 2017	Amendment	$508,000	$408,000vs Feb 2, 2016	9	SEC filing
Feb 2, 2016	Initial	$100,000	No comparison	1	SEC filing
Feb 1, 2016	Initial	$350,000	No comparison	3	SEC filing
Nov 26, 2014	Initial	$100,000	No comparison	1	SEC filing

Offering details

Securities: Equity
Exemptions: 06c
Duration over one year: Yes
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-256471

Source: Form D, filed May 10, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Gerry Berg	Executive
Vladimir Bogin	Director
John Chiplin	Director
Thomas E Ichim	Director
Alan Lewis	Director
Hong Ma	Director
John Peck	Director
Dimitrios Nikolaos Theofilopoulos	Executive
Samuel C Wagner	Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:

9255 Towne Centre Dr., Suite 450
San Diego, CA, 92121